国际病理科学与临床杂志 2009, 29(5) 412-415 DOI:     ISSN: 1673-2588 CN: 43-1458/R

本期目录 | 下期目录 | 过刊浏览 | 高级检索                                                            [打印本页]   [关闭]
综述
扩展功能
本文信息
Supporting info
PDF(819KB)
[HTML全文]
参考文献[PDF]
参考文献
服务与反馈
把本文推荐给朋友
加入我的书架
加入引用管理器
引用本文
Email Alert
文章反馈
浏览反馈信息
本文关键词相关文章
RASSF1A; Ras;抑癌基因;肿瘤
本文作者相关文章
PubMed
RASSF1A及其在肿瘤发生中的作用
肖伟升综述廖爱军审校
南华大学附属第一医院消化内科,  湖南 衡阳 421001
摘要

RASSF1A(Ras-assotiation domain family 1 A)基因是一个新型抑癌基因。目前的研究已经在许多肿瘤中发现了这个基因的失活。虽然这个基因的失活可因基因缺失或突变引起,但最常见的原因还是该基因的启动子区甲基化紊乱。这种表形遗传学改变被证实是肿瘤形成的一个早期事件,是肿瘤形成的主要因素之一。RASSF1A有多个结构域,被认为是一种潜在的Ras癌蛋白效应分子,能与活化的Ras结合,调节凋亡及细胞周期信号通路,在细胞的凋亡、增殖、分化及维持细胞的稳定中发挥多种生物学效应,与肿瘤的发生发展密切相关。

关键词 RASSF1A; Ras;抑癌基因;肿瘤  
RASSF1A and its role in tumorigenesis
XIAO Weisheng,  LIAO Aijun
Department of Gastroenterology, First Affliated Hospital, Nanhua University, Hengyang Hunan 421001, China
Abstract:

RASSF1A (Ras-assotiation domain family 1 A) is a recently discovered new tumor suppressor. Recently, it has been shown that silencing of RASSF1A was found in many tumors. Although it can be inactivated by gene deletion or mutations, the most common reason for RASSF1A dyfunction is due to the silence of the gene by inappropriate methylation in promoter region. This epigenetic mechanism is thought as an early incidence and plays a major role in the development of cancer. RASSF1A contains several structural domains and is an potential effector of the Ras oncoprotein. It is able to bind to the activated Ras and participates in regulating the signal pathway of apoptosis and cell cycle. It is closely associated with the development of tumor and exerts multiple functions in cellular apoptosis, cycle, proliferation, differentiation and stability.

Keywords: RASSF1A;Ras;tumor suppressor gene;tumor  
收稿日期 2009-07-06 修回日期 2009-09-14 网络版发布日期  
DOI:
基金项目:

通讯作者: 廖爱军
作者简介:
作者Email: aijun.liao@163.com

参考文献:


[1]Dammann R,Li C,Yoon JH,et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3[J].Nat Genet, 2000,25(3):315-319.
[2]Lerman MI,Minna JD.The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppre-ssor genes[J]. Cancer Res, 2000,60(21):6116-6133.
[3]van der Weyden L,Adams DJ.The Ras-assoeiation domain family(RASSF) members and their role in human tumourigenesis[J].Biochim Biophys Aeta, 2007,1776(1):58-85.
[4]Verma SK, Ganesan TS, Parker PJ. The tumour suppressor RASSF1A is a novel substrate of PKC[J].FEBS Lett, 2008,582(15):2270-2276.
[5]Levitt NC, Hickson ID. Caretaker tumour suppressor genes that defend genome integrity[J].Trends Mol Med, 2002,8(4):179-186.
[6]Shiloh Y. ATM and related protein kinases: safeguarding genome integrity[J]. Nat Rev Cancer, 2003,3(3):155-168.
[7]Thaler S, Hhnel PS, Schad A, et al. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt[J]. Cancer Res, 2009,69(5):1748-1757.
[8]Khokhlatchev A,Rabizadeh S,Xavier R,et al.Identification of a novel Ras-regulated proapoptotic pathway[J]. Curr Bio,2002,12(4):253-265.
[9]Pallarés J,Velasco A,Eritja N,et al.Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma[J]. Mod Pathol,2008,21(6):691-699.
[10]Whang YM, Kim YH, Kim JS, et al. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression[J]. Cancer Res, 2005,65(9):3682-3690.
[11]Yoo YA,Na AR,Lee MS,et al.RASSF1A suppresses oneogenic H-Ras-induced c-Jun N-terminal kinase activation[J].Int J Oneol,2006,29(6):1541-1547.
[12]Khokhlatchev A, Rabizadeh S, Xavier R,et al. Identification of a novel Ras-regulated proapoptotic pathway[J].Curr Biol, 2002,12(4):253-265.
[13]Creasy CL, Ambrose DM, Chernoff J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain[J]. J Biol Chem, 1996,271(35):21049-21053.
[14]Oh HJ, Lee KK, Song SJ,et al.Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis[J].Cancer Res, 2006,66(5):2562-2569.
[15]Guo C, Tommasi S, Liu L,et al. RASSF1A is part of a complex similar to the drosophila Hippo/Salvador/Lats tumor-suppressor network[J]. Curr Biol, 2007,17(8):700-705.
[16]Rabizadeh S, Xavier RJ, Ishiguro K,et al.The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death[J]. J Biol Chem, 2004,279(28):29247-29254.
[17]Baksh S, Tommasi S, Fenton S,et al. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death[J].Mol Cell, 2005,18(6):637-650.
[18]Vos MD,Dallol A,Eckfeld K,et al.The RASSF1A tumor suppressor activates Bax via MOAP-1[J].J Biol Chem,2006,281(8):4557-4563.
[19]Foley CJ, Freedman H, Choo SL,et al. Dynamics of RASSF1A/MOAP-1 association with death receptors[J]. Mol Cell Biol, 2008,28(14):4520-4535.
[20]Harvey K, Tapon N.The Salvador-Warts-Hippo pathway-an emerging tumour-suppressor network[J].Nat Rev Cancer, 2007,7(3):182-191.
[21]Whitehurst AW, Ram R, Shivakumar L,et al.The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells[J]. Mol Cell Biol, 2008,28(10):3190-3197.
[22]Ura S,Nishina H,Gotoh Y,et al. Activation of the JNK pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis[J].Mol Cell Biol, 2007,27(15):5514-5522.
[23]Fenton SL, Dallol A, Agathanggelou A, et al.Identification of the E1A-regulated transcription factor p120E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene[J]. Cancer Res, 2004,64(1):102-107.
[24]Ahmed-Choudhury J, Agathanggelou A, Fenton SL,et al. Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter[J]. Cancer Res, 2005,65(7):2690-2697.
[25]Song MS, Song SJ, Ayad NG,et al. The tumor suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex[J]. Nat Cell Biol, 2004,6(2):129-137.
[26]Song SJ, Song MS, Kim SJ,et al. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity[J]. Cancer Res, 2009,69(6):2314-2323.
[27]Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine[J]. Mol Cell, 2007,27(1):3-16.
[28]Vos MD, Martinez A, Elam C, et al.A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability[J]. Cancer Res, 2004,64(12):4244-4250.
[29]Shivakumar L, Minna J, Sakamaki T,et al.The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation[J]. Mol Cell Biol, 2002,22(12):4309-4318.
[30]Wassmann K,Benezra R. Mitotic checkpoints: from yeast to cancer[J]. Cold Spring Harb Symp Quant Biol, 2000,65(4):361-368.
[31]Song MS, Chang JS, Song SJ,et al.The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles[J]. J Biol Chem, 2005,280(5):3920-3927.
[32]Armesilla AL, Williams JC, Buch MH,et al. Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1)[J]. J Biol Chem, 2004,279(30):31318-31328.
 [33]Wang YC,Yu ZH,Liu C,et al. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients[J]. World J Gastroenterol, 2008,14(19):3074-3080.
[34]Kioulafa M, Kaklamanis L, Mavroudis D,et al. Prognostic significance of RASSF1A promoter methylation in operable breast cancer[J]. Clin Biochem,2009,42(10-11):970-975.
[35]Chan KC,Lai PB,Mok TS,et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma[J]. Clin Chem, 2008,54(9):1528-1536.
[36]Ellinger J,Albers P,Perabo FG,et al. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer[J].J Urol, 2009, 182(1):324-329.

本刊中的类似文章

Copyright by 国际病理科学与临床杂志